--- title: "Psych News Alert: Certain Antidepressants May Increase Risk of Impulse Control Disorder in Parkinson’s Patients" description: Taking serotonergic antidepressants such as serotonin and norepinephrine reuptake inhibitors (SNRIs) or selective serotonin reuptake inhibi... image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/neurons-iStock-1434534146-Jun-24-2025-09-41-14-4806-PM.jpg --- 1/5/24 12:00 AM # Certain Antidepressants May Increase Risk of Impulse Control Disorder in Parkinson’s Patients ![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert) Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2024/01/certain-antidepressants-may-increase.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2024/01/certain-antidepressants-may-increase.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2024/01/certain-antidepressants-may-increase.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2024/01/certain-antidepressants-may-increase.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2024/01/certain-antidepressants-may-increase.html) ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/neurons-iStock-1434534146-4.jpg?width=200&height=113&name=neurons-iStock-1434534146-4.jpg) Taking serotonergic antidepressants such as serotonin and norepinephrine reuptake inhibitors (SNRIs) or selective serotonin reuptake inhibitors (SSRIs) may increase the risk of patients with Parkinson’s disease developing impulse control disorder, a [study](https://www.ajgponline.org/article/S1064-7481(23)00530-4/fulltext) in *The American Journal of Geriatric Psychiatry* has found. Impulse control disorders—which include a range of behaviors such as excessive gambling, spending, cleaning, and eating—are one of “the most challenging psychiatric syndromes” affecting people living with Parkinson’s disease, wrote Christopher B. Morrow, M.D., M.H.S., of the Johns Hopkins University School of Medicine and colleagues. Morrow and colleagues examined data from 1,045 individuals (mean age, 63 years) who were participating in the [Parkinson’s Progression Markers Initiative](https://www.ppmi-info.org/) (PPMI). The researchers ascertained the presence of impulse control disorder via the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease (QUIP). Antidepressant use was defined based on medication logs for each participant. Depressive symptoms were captured using the Geriatric Depression Scale. Participants were in the PPMI study for a mean of 7.2 years and had a mean of 7.4 visits during the study period. Data for the current study were collected between July 2010 and June 2023. Impulse control disorder was present in 10% of participants at visit one and in 27% of participants at some point during the study. In addition, 39% of participants were prescribed an antidepressant during the study. Patients who took serotonergic antidepressants had a 40% greater risk of having impulse control disorder compared with those who did not take antidepressants. Dopamine agonist use, depression, disease duration, and male sex were also associated with an increased probability of impulse control disorder. The findings also suggest that bupropion, which is not serotonergic, was not associated with an increased risk of impulse control disorder. However, the researchers noted that there were relatively few participants taking bupropion prior to assessments for impulse control disorder compared with those taking serotonergic antidepressants (4% versus 21%), so it is possible their analysis was underpowered to detect the true relationship between impulse control disorder and bupropion. Morrow and colleagues noted that while one strength of the study is that the data are “from a large, geographically diverse, longitudinal dataset,” there are several limitations to consider, including the use QUIP to define impulse control disorder (they wrote, “a definitive diagnosis of ICD requires a more detailed clinical assessment than the QUIP provides”). “[C]linicians making treatment decisions for patients with depression/anxiety and co-existing [impulse control disorder] may consider alternatives to serotonergic antidepressants like bupropion, brain stimulation techniques, psychotherapy, or other novel treatment strategies,” the researchers wrote. “Prospective studies are ultimately needed to expand upon our findings, confirm a causal link between antidepressant use and [impulse control disorder], and clarify the neurobiological changes giving rise to these symptoms.” For related information, see *The American Journal of Psychiatry *article “[Impulse Control Disorders in Parkinson’s Disease](https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2018.18040465).” (Image: Getty Images/iStock/koto_feja) --- **Don't miss out!** To learn about newly posted articles in *Psychiatric News,* please sign up [here](https://appi.org/pnpubalert). [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/x_logo-Jun-24-2025-09-41-13-1329-PM.jpg?width=25&height=25&name=x_logo-Jun-24-2025-09-41-13-1329-PM.jpg)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/Twitter_Bird-Jun-24-2025-09-42-34-1010-PM.png) **[Follow *Psychiatric News* on X!](https://twitter.com/PsychiatricNews)** [SSRIs](https://alert.psychnews.org/tag/ssris), [antidepressants](https://alert.psychnews.org/tag/antidepressants), [Parkinson's disease](https://alert.psychnews.org/tag/parkinsons-disease), [The American Journal of Geriatric Psychiatry](https://alert.psychnews.org/tag/the-american-journal-of-geriatric-psychiatry), [impulse control disorders](https://alert.psychnews.org/tag/impulse-control-disorders), [SNRIs](https://alert.psychnews.org/tag/snris), [gambling](https://alert.psychnews.org/tag/gambling) ## Related posts [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/teen_shutterstock_128632589-Jun-24-2025-04-29-03-0319-PM.jpg?height=200&name=teen_shutterstock_128632589-Jun-24-2025-04-29-03-0319-PM.jpg) ](https://alert.psychnews.org/2018/02/ssris-appear-superior-to-ssnris-for.html) [SSRIs](https://alert.psychnews.org/tag/ssris), [Journal of the American Academy of Child and Adole](https://alert.psychnews.org/tag/journal-of-the-american-academy-of-child-and-adole), [meta-analysis](https://alert.psychnews.org/tag/meta-analysis), [pediatric anxiety](https://alert.psychnews.org/tag/pediatric-anxiety), [SNRIs](https://alert.psychnews.org/tag/snris), [Jeffrey Strawn](https://alert.psychnews.org/tag/jeffrey-strawn) ## [SSRIs Appear Superior to SSNRIs for Pediatric Anxiety, Study Shows](https://alert.psychnews.org/2018/02/ssris-appear-superior-to-ssnris-for.html) ![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 2/27/18 12:00 AM Selective serotonin reuptake inhibitors (SSRIs) appear to be superior to selective... [ Read more ](https://alert.psychnews.org/2018/02/ssris-appear-superior-to-ssnris-for.html) [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/AVvXsEjlR3YUe927_czdbdvCgXSlf58yyATLMknGLl1uJpJpdaOCrwYaPUa8SGZQ_k01vpti_gVP1S7JS7vBR9LTYB4dNC_3JKA46xHoFZ_BqC26DImEzRP1MlpEDgd0xeg12Ffc9IX07LEMnZl4M-3.jpg?height=200&name=AVvXsEjlR3YUe927_czdbdvCgXSlf58yyATLMknGLl1uJpJpdaOCrwYaPUa8SGZQ_k01vpti_gVP1S7JS7vBR9LTYB4dNC_3JKA46xHoFZ_BqC26DImEzRP1MlpEDgd0xeg12Ffc9IX07LEMnZl4M-3.jpg) ](https://alert.psychnews.org/2025/04/ssrisnri-use-while-pregnant-does-not.html) [SSRI](https://alert.psychnews.org/tag/ssri), [depression](https://alert.psychnews.org/tag/depression), [anxiety](https://alert.psychnews.org/tag/anxiety), [pregnancy](https://alert.psychnews.org/tag/pregnancy), [SNRI](https://alert.psychnews.org/tag/snri), [antidepressant](https://alert.psychnews.org/tag/antidepressant) ## [SSRI/SNRI Use While Pregnant Does Not Seem to Increase Risk of Depression or Anxiety in Children](https://alert.psychnews.org/2025/04/ssrisnri-use-while-pregnant-does-not.html) ![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 4/11/25 12:00 AM [ Read more ](https://alert.psychnews.org/2025/04/ssrisnri-use-while-pregnant-does-not.html) [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/neurons_iStock-1053434168-Jun-24-2025-06-10-30-6408-PM.jpg?height=200&name=neurons_iStock-1053434168-Jun-24-2025-06-10-30-6408-PM.jpg) ](https://alert.psychnews.org/2019/02/hyperactive-brain-cells-may-explain-why.html) [SSRIs](https://alert.psychnews.org/tag/ssris), [Ph.D.](https://alert.psychnews.org/tag/ph-d-), [Molecular Psychiatry](https://alert.psychnews.org/tag/molecular-psychiatry), [hyperactivity](https://alert.psychnews.org/tag/hyperactivity), [neurons](https://alert.psychnews.org/tag/neurons) ## [Hyperactive Brain Cells May Explain Why Some Patients Don’t Respond to SSRIs](https://alert.psychnews.org/2019/02/hyperactive-brain-cells-may-explain-why.html) ![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 2/5/19 12:00 AM Not everyone with depression responds to treatment with selective serotonin reuptake inhibitors... [ Read more ](https://alert.psychnews.org/2019/02/hyperactive-brain-cells-may-explain-why.html) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Psychiatric News Alert", "url" : "https://alert.psychnews.org/author/psychiatric-news-alert" }, "dateModified" : "2025-06-24T21:43:04.438Z", "datePublished" : "2024-01-05T05:00:00.000Z", "headline" : "Psych News Alert: Certain Antidepressants May Increase Risk of Impulse Control Disorder in Parkinson’s Patients", "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/neurons-iStock-1434534146-Jun-24-2025-09-41-14-4806-PM.jpg" ], "mainEntityOfPage" : { "@id" : "https://alert.psychnews.org/2024/01/certain-antidepressants-may-increase.html", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg" } } } ```